Icici Prudential Asset Management CO LTD Gilead Sciences, Inc. Transaction History
Icici Prudential Asset Management CO LTD
- $750 Million
- Q1 2025
A detailed history of Icici Prudential Asset Management CO LTD transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Icici Prudential Asset Management CO LTD holds 52,398 shares of GILD stock, worth $5.69 Million. This represents 0.78% of its overall portfolio holdings.
Number of Shares
52,398
Previous 129,954
59.68%
Holding current value
$5.69 Million
Previous $12 Million
51.09%
% of portfolio
0.78%
Previous 1.36%
Shares
18 transactions
Others Institutions Holding GILD
# of Institutions
2,288Shares Held
997MCall Options Held
9.62MPut Options Held
10M-
Black Rock Inc. New York, NY121MShares$13.1 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$12.7 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.46 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$5.93 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$5.81 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $136B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...